Carzomib 60mg Injection

About

Carzomib 60mg Injection is a proteasome inhibitor used in the treatment of multiple myeloma, a type of blood cancer affecting plasma cells. It works by selectively and irreversibly inhibiting the chymotrypsin-like activity of the 20S proteasome, a multi-enzyme complex responsible for degrading ubiquitinated proteins. This inhibition leads to an accumulation of misfolded and ubiquitinated proteins within cancer cells, triggering cellular stress, apoptosis (programmed cell death), and ultimately inhibiting tumor growth. Carzomib is typically administered intravenously and is often used in patients who have received at least one prior therapy for multiple myeloma, or in combination with other agents for newly diagnosed cases. Its targeted mechanism helps to overcome resistance to other treatments and improve patient outcomes.

Uses

• Treatment of relapsed or refractory multiple myeloma.
• Used in combination with other agents for multiple myeloma.
• Management of newly diagnosed multiple myeloma.
• Part of a treatment regimen for specific blood cancers.

Directions For Use

Administered intravenously by a healthcare professional. Dosage and frequency are determined by your doctor.

Benefits

• Effective in relapsed/refractory multiple myeloma.
• Improves progression-free survival.
• Can be used in combination therapies.
• Targeted mechanism of action.
• Helps overcome treatment resistance.
• Contributes to disease control.

Side Effects

• Thrombocytopenia (low platelet count)
• Anemia
• Neutropenia (low white blood cell count)
• Fatigue
• Nausea
• Diarrhea
• Dyspnea (shortness of breath)
• Hypertension (high blood pressure)
• Peripheral neuropathy
• Pyrexia (fever)
• Headache
• Cough

Safety Measures

• Alcohol - Avoid alcohol during treatment as it may exacerbate gastrointestinal side effects and increase liver strain.
• Pregnancy - Contraindicated in pregnancy due to potential for fetal harm. Women of childbearing potential must use effective contraception.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if the drug is excreted in human milk and could harm the infant.
• Liver - Use with caution in patients with hepatic impairment. Dose adjustments may be necessary, and liver function should be monitored.
• Kidney - Use with caution in patients with renal impairment. Dose adjustments may be required based on creatinine clearance.
• Lung - Monitor for pulmonary hypertension and dyspnea. Patients with pre-existing lung conditions should be closely observed.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.